Your browser doesn't support javascript.
loading
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial.
Triulzi, Tiziana; Bianchini, Giampaolo; Di Cosimo, Serena; Pienkowski, Tadeusz; Im, Young-Hyuck; Bianchi, Giulia Valeria; Galbardi, Barbara; Dugo, Matteo; De Cecco, Loris; Tseng, Ling-Ming; Liu, Mei-Ching; Bermejo, Begoña; Semiglazov, Vladimir; Viale, Giulia; de la Haba-Rodriguez, Juan; Oh, Do-Youn; Poirier, Brigitte; Valagussa, Pinuccia; Gianni, Luca; Tagliabue, Elda.
Afiliação
  • Triulzi T; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Bianchini G; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Di Cosimo S; DRAST, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Pienkowski T; Oncology and Breast Diseases Department, Postgraduate Medical Education Center, Warsaw, Poland.
  • Im YH; Department of Medicine, Samsung Medical Center, Seoul, Republic of Korea.
  • Bianchi GV; Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Galbardi B; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Dugo M; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • De Cecco L; DRAST, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Tseng LM; Taipei-Veterans General Hospital, National Yang-Ming University, Taiwan.
  • Liu MC; Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan.
  • Bermejo B; Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, Valencia, Spain.
  • Semiglazov V; NN Petrov Research Institute of Oncology, St Petersburg, Russia.
  • Viale G; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • de la Haba-Rodriguez J; Hospital Reina Sofia, Córdoba, Spain.
  • Oh DY; Division of Medical Oncology, Seoul National University Hospital Cancer Research Institute, Seoul National University College of Medicine, Republic of Korea.
  • Poirier B; Centre des Maladies du sein, Hôpital du Saint-Sacrement, CHU de Québec, Canada.
  • Valagussa P; Fondazione Michelangelo, Milan, Italy.
  • Gianni L; Fondazione Michelangelo, Milan, Italy.
  • Tagliabue E; Fondazione Gianni Bonadonna, Milan, Italy.
Mol Oncol ; 16(12): 2355-2366, 2022 06.
Article em En | MEDLINE | ID: mdl-34816585
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article